1. Home
  2. CADL vs NAMSW Comparison

CADL vs NAMSW Comparison

Compare CADL & NAMSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • NAMSW
  • Stock Information
  • Founded
  • CADL 1999
  • NAMSW N/A
  • Country
  • CADL United States
  • NAMSW Netherlands
  • Employees
  • CADL N/A
  • NAMSW 29
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • Sector
  • CADL Health Care
  • NAMSW Health Care
  • Exchange
  • CADL Nasdaq
  • NAMSW Nasdaq
  • Market Cap
  • CADL 185.2M
  • NAMSW N/A
  • IPO Year
  • CADL 2021
  • NAMSW N/A
  • Fundamental
  • Price
  • CADL $6.36
  • NAMSW $8.90
  • Analyst Decision
  • CADL Strong Buy
  • NAMSW
  • Analyst Count
  • CADL 1
  • NAMSW 0
  • Target Price
  • CADL $11.00
  • NAMSW N/A
  • AVG Volume (30 Days)
  • CADL 585.1K
  • NAMSW N/A
  • Earning Date
  • CADL 08-08-2024
  • NAMSW N/A
  • Dividend Yield
  • CADL N/A
  • NAMSW N/A
  • EPS Growth
  • CADL N/A
  • NAMSW N/A
  • EPS
  • CADL N/A
  • NAMSW N/A
  • Revenue
  • CADL N/A
  • NAMSW N/A
  • Revenue This Year
  • CADL N/A
  • NAMSW N/A
  • Revenue Next Year
  • CADL N/A
  • NAMSW N/A
  • P/E Ratio
  • CADL N/A
  • NAMSW N/A
  • Revenue Growth
  • CADL N/A
  • NAMSW N/A
  • 52 Week Low
  • CADL $0.66
  • NAMSW N/A
  • 52 Week High
  • CADL $14.30
  • NAMSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • CADL 47.84
  • NAMSW 46.37
  • Support Level
  • CADL $5.58
  • NAMSW $8.30
  • Resistance Level
  • CADL $7.34
  • NAMSW $9.77
  • Average True Range (ATR)
  • CADL 0.57
  • NAMSW 0.27
  • MACD
  • CADL 0.10
  • NAMSW -0.10
  • Stochastic Oscillator
  • CADL 44.32
  • NAMSW 28.57

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: